Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Florence Bianic, Rosanne Campbell, Vidya Damera, Paolo De Simone, Alessandro Roccia, Jill Gregson & Jean-Francois Ricci. (2016) Cost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the Italian setting. Journal of Medical Economics 19:9, pages 866-873.
Read now
Read now
Domenico Santoro, Vincenzo Pellicanò, Luca Visconti, Gianluca Trifirò, Michele Buemi & Valeria Cernaro. (2015) An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease. Expert Opinion on Investigational Drugs 24:9, pages 1199-1218.
Read now
Read now
Articles from other publishers (27)
Bethany Nahri So & K. Rajender Reddy. (2023) Liver Transplantation for the Nonhepatologist. Medical Clinics of North America 107:3, pages 605-621.
Crossref
Crossref
Emily A. Bosselmann, Fabian Dranicki, Alejandro Campos-Murguia, Björn Hartleben, Heiner Wedemeyer, Elmar Jaeckel & Richard Taubert. (2023) Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus. Frontiers in Transplantation 2.
Crossref
Crossref
Noemi Zorzetti, Augusto Lauro, Simone Khouzam & Ignazio Roberto Marino. (2022) Immunosuppression, Compliance, and Tolerance After Orthotopic Liver Transplantation: State of the Art. Experimental and Clinical Transplantation 20:Suppl 1, pages 3-9.
Crossref
Crossref
Devivasha Bordoloi, Choudhary Harsha, Ganesan Padmavathi, Kishore Banik, Bethsebie Lalduhsaki Sailo, Nand Kishor Roy, Sosmitha Girisa, Krishan Kumar Thakur, Amrita Devi Khwairakpam, Arunachalam Chinnathambi, Tahani Awad Alahmadi, Sulaiman Ali Alharbi, Mehdi Shakibaei & Ajaikumar B. Kunnumakkara. (2022) Loss of TIPE3 reduced the proliferation, survival and migration of lung cancer cells through inactivation of Akt/mTOR, NF-κB, and STAT-3 signaling cascades. Life Sciences 293, pages 120332.
Crossref
Crossref
Ane M. Andres, Paloma Talayero, Alida Alcolea Sanchez, Alba Sanchez Galán, Javier Serradilla Rodríguez, Alba Bueno Jimenez, Rocío Gonzalez Sacristan, Pablo Stringa, Rodrigo Papa Gobbi, Maria Lasa Lazaro, Mariana Díaz Almirón, Esther Ramos Boluda, Manuel Lopez Santamaría & Francisco Hernández Oliveros. (2021) Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long‐term benefits. Transplant International 34:10, pages 1895-1907.
Crossref
Crossref
Khalid Ibrahim Bzeizi, Richard Smith, Ali Albenmousa, Madhukar Dama, Faisal Aba-Alkhail, Rajiv Jalan & Dieter Broering. (2021) Long-Term Outcomes of Everolimus Therapy in De Novo Liver Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Transplantation Proceedings 53:1, pages 148-158.
Crossref
Crossref
Barbara Marconi, Anna Campanati, Melania Giannoni, Francesca Ricotti, Tommaso Bianchelli & Annamaria Offidani. (2020) Analysis of neoplastic skin complications in transplant patients: experience of an Italian multidisciplinary transplant unit. Giornale Italiano di Dermatologia e Venereologia 155:3.
Crossref
Crossref
Yingzi Ming & Meng Yu. 2018. Genetic Diversity and Disease Susceptibility. Genetic Diversity and Disease Susceptibility.
Alexandra Frey, Katja Piras-Straub, Andreas Walker, Jörg Timm, Guido Gerken & Kerstin Herzer. (2018) The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotype. Transplant Infectious Disease 20:1, pages e12803.
Crossref
Crossref
Björn Nashan. (2018) mTOR Inhibition and Clinical Transplantation. Transplantation 102:2S, pages S19-S26.
Crossref
Crossref
David M. Newland & Thomas L. Nemeth. 2018. Solid Organ Transplantation in Infants and Children. Solid Organ Transplantation in Infants and Children
149
182
.
A. Frey, E.-M. Ecker, K. Piras-Straub, A. Walker, T.G. Hofmann, J. Timm, B.B. Singer, G. Gerken & K. Herzer. (2017) Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo. Transplantation Proceedings 49:8, pages 1947-1955.
Crossref
Crossref
Denize Jussara Rupolo Dall'Agnol, Luciana Aparecida Corá, Maria do Carmo Borges Teixeira, Maysa Bruno de Lima, Loyane Almeida Gama, José Ricardo de Arruda Miranda & Madileine Francely Américo. (2017) Gastrointestinal disorders after immunosuppression: an experimental model to evaluate the influence of monotherapy on motility parameters. Experimental Physiology 102:8, pages 924-933.
Crossref
Crossref
David M. Newland & Thomas L. Nemeth. 2017. Solid Organ Transplantation in Infants and Children. Solid Organ Transplantation in Infants and Children
1
34
.
Antonio Pinto, Annika Jahn, Moritz Benjamin Immohr, Alexander Jenke, Laura Döhrn, Markus Kornfeld, Artur Lichtenberg, Payam Akhyari & Udo Boeken. (2016) Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model. Inflammation 39:5, pages 1771-1782.
Crossref
Crossref
Adriana Mika & Piotr Stepnowski. (2016) Current methods of the analysis of immunosuppressive agents in clinical materials: A review. Journal of Pharmaceutical and Biomedical Analysis 127, pages 207-231.
Crossref
Crossref
Kerstin Herzer, Christian P. Strassburg, Felix Braun, Cornelius Engelmann, Markus Guba, Frank Lehner, Silvio Nadalin, Andreas Pascher, Marcus N. Scherer, Andreas A. Schnitzbauer, Tim Zimmermann, Björn Nashan & Martina Sterneck. (2016) Selection and use of immunosuppressive therapies after liver transplantation: current German practice. Clinical Transplantation 30:5, pages 487-501.
Crossref
Crossref
Domenico Santoro, Vincenzo Pellicanò, Luca Visconti, Viviana Lacava, CarloAlberto Ricciardi, Antonio Lacquaniti, Valeria Cernaro & Michele Buemi. (2018) New options for the management of polycystic kidney disease. Giornale di Tecniche Nefrologiche e Dialitiche 28:2, pages 143-152.
Crossref
Crossref
Nicolas Picard, Stein Bergan, Pierre Marquet, Teun van Gelder, Pierre Wallemacq, Dennis A. Hesselink & Vincent Haufroid. (2016) Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs. Therapeutic Drug Monitoring 38:Supplement 1, pages S57-S69.
Crossref
Crossref
Alberto Baroja-Mazo, Beatriz Revilla-Nuin, Pablo Ramírez & José A Pons. (2016) Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation. World Journal of Transplantation 6:1, pages 183.
Crossref
Crossref
Giuseppina Pisano, Anna L Fracanzani, Lucio Caccamo, Maria F Donato & Silvia Fargion. (2016) Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. World Journal of Gastroenterology 22:40, pages 8869.
Crossref
Crossref
Greg J. McKenna & Goran B.G. Klintmalm. 2016. Molecules to Medicine with mTOR. Molecules to Medicine with mTOR
293
315
.
Jonathan T. Busada, Bryan A. Niedenberger, Ellen K. Velte, Brett D. Keiper & Christopher B. Geyer. (2015) Mammalian target of rapamycin complex 1 (mTORC1) Is required for mouse spermatogonial differentiation in vivo. Developmental Biology 407:1, pages 90-102.
Crossref
Crossref
Daniele Alesini, Claudia Mosillo, Giuseppe Naso, Enrico Cortesi & Roberto Iacovelli. (2015) Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinoma. Therapeutic Advances in Urology 7:5, pages 286-294.
Crossref
Crossref
Cheng-Yong Tang, Ai Shen, Xu-Fu Wei, Qing-Dong Li, Rui Liu, He-Jun Deng, Yong-Zhong Wu & Zhong-Jun Wu. (2015) Everolimus in de novo liver transplant recipients: a systematic review. Hepatobiliary & Pancreatic Diseases International 14:5, pages 461-469.
Crossref
Crossref
Sandesh Parajuli, David Foley, Arjang Djamali & Didier Mandelbrot. (2015) Renal Function and Transplantation in Liver Disease. Transplantation 99:9, pages 1756-1764.
Crossref
Crossref
Chrysoula Pipili. (2015) Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?. World Journal of Hepatology 7:12, pages 1606.
Crossref
Crossref